Mixed donor chimerism and low level iduronidase expression may be adequate for neurodevelopmental protection in Hurler syndrome

Journal of Pediatrics

Volumn 147, Issue 1, 2005, Pages 106-108

  Conway, Jennifer ^a   Dyack, Sarah ^a   Crooks, Bruce N A ^a   Fernandez, Conrad V ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; LEVO IDURONIDASE;

ARTICLE; CASE REPORT; CHIMERA; CLINICAL FEATURE; COARSE FACE; DISEASE SEVERITY; DONOR; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOTE; HUMAN; HUMAN CELL; HURLER SYNDROME; INFANT; INTELLIGENCE TEST; LANGUAGE TEST; MALE; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; DEVELOPMENTAL DISABILITIES; HUMANS; IDURONIDASE; INFANT; MALE; MUCOPOLYSACCHARIDOSIS I; TRANSPLANTATION CHIMERA; TREATMENT OUTCOME;

EID: 22144442824     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.03.005     Document Type: Article

References (11)

1. M.A. Cleary, and J.E. Wraith The presenting features of mucopolysaccharidosis Type IH (Hurler Syndrome) Acta Paediatric 84 1995 337 339
2. E.G. Shapiro, L.A. Lockman, M. Balthazor, and W. Krivit Neuropsychological outcomes of several storage diseases with or without bone marrow transplant J Inher Metab Dis 18 1995 413 429
3. J.E. Wraith, L.A. Clarke, M. Beck, E.H. Kolodny, G.M. Pastores, and J. Muenzer Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase J Pediatrics 144 2004 581 588
4. C. Peters Neuropsychological development of children with Hurler syndrome following hematopoietic stem cell transplant Pediatr Transplant 2 1998 250 253
5. C. Peters, E. Shapiro, J. Anderson, J.P. Henslee-Downey, M.R. Klemperer, and M.J. Cowan Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA haploidentical related donor bone marrow transplantation in 54 children Blood 7 1998 2601 2608
6. C. Peters, M. Balthazor, E.G. Shapiro, J.R. King, C. Kollman, and J.D. Hegland Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome Blood 87 1996 4894 4902
7. W. Krivit, C. Peters, and E.G. Shapiro Bone marrow transplant as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Marteaux-Lamy, and Sly syndromes and Gaucher disease type III Curr Opin Neurol 12 1999 167 176
8. M.J. Cowan Bone marrow transplant for the treatment of genetic disease Clinical Biochemistry 24 1991 375 381
9. N. Guffon, G. Souillet, I. Maire, J. Straczek, and P. Guibaud Follow-up of nine patients with Hurler Syndrome after bone marrow transplant J Pediatr 133 1998 119 125
10. Y. Takakashi, K. Sukegawa, M. Aoki, K. Suzuki, H. Sakaguchi, and M. Watanabe Evaluation of accumulated mucoploysaccharides in the brain if patients with mucopolysaccharidoses by H-magnetic resonance spectroscopy before and after bone marrow transplant Pediatr Res 49 2001 349 355
11. C.B. Whitley, G.B. Kumar, P.N. Chang, C.G. Summers, B.R. Blazar, and M.Y. Tsai Long term outcome of Hurler syndrome following BMT Am J Med Genet 46 1993 209 218